Trident Texofab Limited has announced the successful completion of a separate meeting of independent directors held on March 27, 2026, in accordance with regulatory compliance requirements. The meeting was conducted pursuant to Schedule IV of the Companies Act, 2013 and Regulation 25(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Meeting Details and Venue

The independent directors' meeting took place at the company's office located at 2004, 2nd Floor, North Extension, Falsawadi, Begumpura, Nodh 4/1650, Sahara Darwaja, Surat-395003, Gujarat. The meeting was efficiently conducted within a 25-minute timeframe, commencing at 05:00 p.m. and concluding at 05:25 p.m.

Key Agenda Items Discussed

The independent directors addressed three critical governance matters during their separate meeting:

Regulatory Compliance and Governance

The meeting demonstrates Trident Texofab Limited's commitment to maintaining strong corporate governance standards. The independent directors reviewed the performance of non-independent directors and evaluated the board's overall effectiveness. Additionally, they conducted a comprehensive assessment of the Chairman's performance, incorporating perspectives from both executive and non-executive directors.

Information Flow Evaluation

A significant focus of the meeting was assessing the quality, quantity, and timeliness of information flow between the company's management and the Board. This evaluation ensures that directors receive necessary information to effectively and reasonably perform their fiduciary duties.

Company Secretary Confirmation

Rahul Jariwala, Company Secretary and Compliance Officer (Membership No. A70164), digitally signed the disclosure document on March 27, 2026, confirming the meeting's completion and requesting the stock exchange to take the information on record. The company maintains its listing on BSE Limited under the stock ID TTFL with scrip code 540726.

Trident Texofab Limited reported mixed financial results for Q3FY26, with revenue declining year-on-year despite achieving significant profit growth. The semi-composite textile manufacturing company continues its strategic shift from trading to manufacturing operations.

Financial Performance Overview

The company's Q3FY26 financial performance showed contrasting trends across key metrics:

Revenue from operations declined 19% year-on-year to ₹2,574.09 lakhs in Q3FY26, compared to ₹3,168.94 lakhs in Q3FY25. Total operating expenses decreased proportionally by 18% to ₹2,409.59 lakhs.

Profitability Metrics

Despite revenue challenges, the company demonstrated resilience in profit generation. PAT registered impressive growth of 90% year-on-year, reaching ₹57.01 lakhs compared to ₹29.98 lakhs in Q3FY25. However, EBITDA margins compressed to 6.39% from 7.33% in the corresponding quarter last year.

Interest costs showed significant improvement, declining 37% year-on-year to ₹87.33 lakhs from ₹138.25 lakhs in Q3FY25. Depreciation remained relatively stable at ₹40.96 lakhs.

Nine-Month Performance

For the nine-month period FY26, the company reported revenue of ₹8,445.23 lakhs. PAT for 9MFY26 stood at ₹361.65 lakhs, registering growth of 65% year-on-year, indicating sustained profitability improvements despite revenue pressures.

Business Model Transformation

The company continues its strategic transition from a pure trading entity to a manufacturing-focused textile player. This shift, initiated under the "Shifting Gears" strategy in FY19, has transformed Trident into a semi-composite textile manufacturer producing polyester and poly-blend fabrics.

The manufacturing division remains the core strength of the company's operations, with management focusing on future growth opportunities through this vertical. The company's expansive product portfolio includes home furnishing, garments, suiting, shirting, technical textiles, and various fabric categories across both manufacturing and trading verticals.